Develops biotechnology products.
Mar 2025Revenue $20.3M/yrExpenses $22.6M/yr
No trend
Figures by year
When will Cellyan Biotechnology be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Mar 2025, revenue was $20.3M and expenses $22.6M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Mar 2025 | $20.3M | $22.6M | −$2.28M |
| Mar 2024 | $16.7M | $18.6M | −$1.95M |
| Mar 2023 | $12.6M | $14.3M | −$1.79M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.